What's Happening?
The US Food and Drug Administration (FDA) has decided to exempt the low-calorie sweetener tagatose from 'added sugar' labeling requirements on US food labels. This decision follows a campaign by Virginia-based startup Bonumose, which has been advocating
for the change due to tagatose's health benefits and lower caloric content compared to regular sugar. The FDA's exemption is expected to increase the use of tagatose by food manufacturers, as it no longer needs to be listed as an 'added sugar' on nutrition labels. Bonumose plans to scale up production significantly, with support from partners like ASR Group and Hershey, to meet the anticipated demand.
Why It's Important?
The FDA's decision to exempt tagatose from 'added sugar' labeling is significant for the food industry, as it opens up new opportunities for manufacturers to use this sweetener without the negative connotations associated with added sugars. Tagatose's low glycemic index and prebiotic effects make it an attractive alternative to traditional sugars, potentially benefiting consumers seeking healthier options. This regulatory change could lead to increased innovation in food products, as manufacturers explore new formulations that incorporate tagatose. The move also highlights the FDA's evolving approach to sugar labeling, which could influence future decisions regarding other alternative sweeteners.
What's Next?
Following the FDA's exemption, Bonumose is focused on increasing its production capacity for tagatose. The company plans to expand beyond its demo-scale plant in Virginia, leveraging partnerships to enhance scalability. As market interest grows, food manufacturers are likely to explore new product lines featuring tagatose, potentially leading to a wider range of low-sugar options for consumers. The FDA's decision may also prompt other companies to seek similar exemptions for alternative sweeteners, potentially reshaping the landscape of sugar labeling and consumer perceptions of sweeteners.
